AI-powered automation for pharmaceutical manufacturing
In GMP manufacturing every change is controlled and every record matters. NuruState focuses on the repetitive work around production, such as maintenance, scheduling, training records and complaint data gathering, with your quality unit in control.
Where repetitive work piles up
Investigation data gathering
Complaints and deviations start with hours of pulling batch records, equipment logs and test data before anyone can look for the root cause.
Training and qualification
Staff must be trained on current procedures before they do the work, and every procedure change creates retraining to assign and track.
Equipment availability
Unplanned failures on packaging lines and utilities stop production and can trigger additional investigation work.
Constrained scheduling
Cleaning requirements, campaign order and material release all limit how the schedule can change when something slips.
Where AI automation usually starts in pharmaceutical plants
The assessment scores all eight opportunities for your facility. These modules are the most common starting points in pharmaceutical manufacturing.
Regulatory context and validation
Finished pharmaceuticals are made under cGMP regulations (21 CFR Parts 210 and 211), which cover written procedures, personnel training, equipment maintenance and complaint handling. Electronic records and signatures fall under 21 CFR Part 11, and systems used in GMP work must be validated. The assessment identifies which records a module would touch and what validation that would require, before you commit to a pilot.
NuruState does not provide legal or regulatory advice. You remain responsible for compliance in your facility; we work within the procedures your quality team already owns.
Who we work with
$20M-$100M revenue manufacturers in FDA-regulated facilities.
Other industries
Find your number
Start with a free 30-minute call. If it fits, the $7,500 assessment scores eight automation opportunities for your plant, with ROI estimates for each.